In the first quarter of 2026, Ozon Pharma recorded net profit of 1.3… (руб · фармацевтика · озон)
In the first quarter of 2026, Ozon Pharma recorded net profit of 1.3 billion rubles according to IFRS. Net profit increased by 30% in Q1 2026 compared to the same period in 2025, reaching 1.3 billion rubles.
Consensus
- Shareholders of OZON Pharmaceuticals approved dividends of 0.27 rubles per share for Q1 2026
- The total amount allocated for dividends is 315.28 million rubles
- Net profit for Q1 2026 was 1.3 billion rubles
- The debt-to-EBITDA ratio was 0.6x
- Dividends will be paid to shareholders who are registered by July 8
Points of divergence
- The total amount allocated for dividends is 315.27 million rubles — kommersant
- Net profit for Q1 2026 was 1.3 billion rubles — vedomosti
- Dividend yield is 0.67% — kommersant
- Net profit for 2025 was 2.3 billion rubles — vedomosti
- Revenue for Q1 2026 was 7 billion rubles — vedomosti
- Adjusted EBITDA for Q1 2026 was 2.5 billion rubles — vedomosti
- The company forecasts revenue growth of 15-25% for 2026 — vedomosti
Coverage (2 sources)
- Ozon Pharma will pay dividends for the first quarter of 2026 — Коммерсантъ
- Ozon Pharma shareholders approved dividends for Q1 — Ведомости